These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 10751080)
1. DOTS in Haiti. Ollé-Goig JE Int J Tuberc Lung Dis; 2000 Mar; 4(3):282-3. PubMed ID: 10751080 [No Abstract] [Full Text] [Related]
2. Systematic drug susceptibility testing: a necessary component of the 'DOTS plus' strategy? Grosset PJ Int J Tuberc Lung Dis; 1999 Jul; 3(7):549-50. PubMed ID: 10423215 [No Abstract] [Full Text] [Related]
3. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus. Kam KM; Yip CW Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147 [TBL] [Abstract][Full Text] [Related]
4. [Reasons for drug-resistant tuberculosis emergence]. Tu DH Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006 [No Abstract] [Full Text] [Related]
5. [Multidrug-resistant tuberculosis. Remarks and reflections on a controversial subject of current utmost importance]. Ausina V Med Clin (Barc); 1996 Jan; 106(1):15-8. PubMed ID: 8750536 [No Abstract] [Full Text] [Related]
6. Trench warfare in a battle with TB. Marshall E Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790 [No Abstract] [Full Text] [Related]
7. [Increasing transmission of tuberculosis in the world. Multiresistant strains are the greatest threat]. Tärnvik A Lakartidningen; 2000 Nov; 97(48):5590-2. PubMed ID: 11187373 [No Abstract] [Full Text] [Related]
8. Pancreatic mass caused by Mycobacterium tuberculosis with reduced drug sensitivity. Small G; Wilks D J Infect; 2001 Apr; 42(3):201-2. PubMed ID: 11545552 [TBL] [Abstract][Full Text] [Related]
9. World tuberculosis control: how far have we to go? Enarson DA Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S219-23. PubMed ID: 11144556 [No Abstract] [Full Text] [Related]
10. Drug resistant tuberculosis in north London. Commun Dis Rep CDR Wkly; 2000 Aug; 10(32):285, 288. PubMed ID: 10958060 [No Abstract] [Full Text] [Related]
11. [Tuberculosis in the 21st centruy]. Casal M Enferm Infecc Microbiol Clin; 2000 May; 18(5):207-8. PubMed ID: 10974762 [No Abstract] [Full Text] [Related]
13. [Multidrug-resistant tuberculosis]. Mori T Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):192-4. PubMed ID: 10088371 [No Abstract] [Full Text] [Related]
14. The Revised National Tuberculosis Control Programme in India: time for revision of treatment regimens and rapid upscaling of DOTS-plus initiative. Bhargava A; Jain Y Natl Med J India; 2008; 21(4):187-91. PubMed ID: 19267041 [No Abstract] [Full Text] [Related]
15. Effect of multidrug resistance on global tuberculosis control. Cox H; Hargreaves S; Ismailov G Lancet; 2003 Nov; 362(9398):1858-9. PubMed ID: 14654338 [No Abstract] [Full Text] [Related]
16. Drug susceptibility profiling of tuberculous meningitis. Nagarathna S; Rafi W; Veenakumari HB; Mani R; Satishchandra P; Chandramuki A Int J Tuberc Lung Dis; 2008 Jan; 12(1):105-7. PubMed ID: 18173886 [TBL] [Abstract][Full Text] [Related]
17. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme. Al-Marri MR Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769 [TBL] [Abstract][Full Text] [Related]